Related Experiment Video
Updated: Mar 18, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage
Min Jeong Chun1, Soo Kyung Hwang1, Hyoun Geun Kim1
1Cancer Cell and Molecular Biology Branch Research Institute National Cancer Center Goyang Gyeonggi Korea.
Abstract:
Previous studies have linked the DNA damage response to mitotic progression machinery. Mitotic kinases, such as Aurora A kinase and Polo-like kinase, are involved in the phosphorylation of cell cycle regulators in response to DNA damage. Here, we investigated the potential involvement of Aurora A kinase in the activation of the Fanconi anemia (FA)/BRCA pathway, which participates in cellular response to DNA interstrand cross-link lesions (ICL). Initially, we detected interactions between Aurora A kinase and FANCA protein, one of the components of the FA nuclear core complex. Silencing of Aurora A kinase led to inhibition of monoubiquitination of FANCD2 and formation of nuclear foci, the final consequences of FA/BRCA pathway activation upon ICL induction. An in vitro kinase assay revealed that Aurora A kinase phosphorylates S165 of FANCA. Moreover, this phosphorylation event was induced by the treatment with mitomycin C (MMC), an ICL-inducing agent. In cells overexpressing S165A mutant FANCA, monoubiquitination of FANCD2 and nuclear foci formation was impaired and cellular sensitivity to MMC was enhanced. These results suggest that S165 phosphorylation by Aurora A kinase is required for proper activation of the FA/BRCA pathway in response to DNA damage.
Insights
Aurora A kinase phosphorylates FANCA at S165, a crucial step for activating the Fanconi anemia (FA)/BRCA pathway. This DNA damage response mechanism is vital for repairing interstrand cross-link lesions.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The DNA damage response (DDR) is intricately linked to cell cycle regulation and mitotic progression.
- Mitotic kinases, including Aurora A kinase, play roles in cellular responses to DNA damage by phosphorylating key regulators.
Purpose of the Study:
- To investigate the role of Aurora A kinase in the activation of the Fanconi anemia (FA)/BRCA pathway.
- To determine if Aurora A kinase directly phosphorylates components of the FA/BRCA pathway.
Main Methods:
- Co-immunoprecipitation to detect protein interactions.
- siRNA-mediated knockdown of Aurora A kinase.
- In vitro kinase assays.
- Analysis of FANCD2 monoubiquitination and nuclear foci formation.
- Site-directed mutagenesis (S165A) and analysis of cellular sensitivity to mitomycin C (MMC).
Main Results:
- Aurora A kinase interacts with FANCA, a core component of the FA pathway.
- Silencing Aurora A kinase inhibits FANCD2 monoubiquitination and nuclear foci formation, key markers of FA pathway activation.
- Aurora A kinase directly phosphorylates FANCA at serine 165 (S165) in vitro.
- MMC treatment induces S165 phosphorylation of FANCA.
- Cells expressing a non-phosphorylatable S165A FANCA mutant show impaired FANCD2 monoubiquitination, reduced foci formation, and increased sensitivity to MMC.
Conclusions:
- Aurora A kinase-mediated phosphorylation of FANCA at S165 is essential for the proper activation of the FA/BRCA pathway.
- This phosphorylation event is a critical step in the cellular response to DNA interstrand cross-link lesions (ICLs).
- Aurora A kinase represents a potential therapeutic target for enhancing DNA repair inhibition in cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Anaphase Promoting Complex
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades

